A strong trend towards SBDD, particularly molecular docking, is evident in recent research on drug repurposing against leishmaniasis, yielding 96 repurposing candidates.
← all excerpts
<i>In silico</i> approaches supporting drug repurposing for Leishmaniasis: a scoping review.
1
—
—